FIELD: medicine. SUBSTANCE: method involves per os administering pentoxiphilin at a dose of 0.2 g three times a day during 30 days and enterosgel at a dose of 15.0 g three times a day during 7 days to patients having blood serum serotonin concentration equal to 1 mcmole/l and erythrocyte deformability index equal to 1.1 conditional units. EFFECT: enhanced effectiveness in normalizing serotonin level in blood plasma. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THERAPEUTIC TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA | 2003 |
|
RU2244528C1 |
METHOD FOR MODELING CHRONIC SEROTONIN INSUFFICIENCY | 2004 |
|
RU2263975C1 |
METHOD FOR TREATING POSTTRAUMATIC HEMORRHAGES INTO OCULAR CAVITY | 2004 |
|
RU2287326C2 |
METHOD FOR TREATING HEMORRHAGES INTO INTERNAL MEDIA AND MEMBRANES OF AN EYE ACCOMPANIED WITH BLOOD PLATELETS HYPERAGGREGATION | 1998 |
|
RU2161020C2 |
METHOD FOR TREATING RETINAL VASCULAR DISEASES ACCOMPANIED WITH HYPOCOAGULATION, HEMORRHAGIC SYNDROME AND SEROTONIN INSUFFICIENCY | 2003 |
|
RU2244529C1 |
METHOD OF TREATMENT OF STATES ACCOMPANYING WITH PLATELET HYPERAGGREGATION | 1997 |
|
RU2150943C1 |
METHOD FOR MODELING RETINOPATHY | 2004 |
|
RU2260856C1 |
METHOD OF ASSAY OF MICROCIRCULATORY TYPE HEMORRHAGIC DIATHESIS IN LATENT PERIOD | 1996 |
|
RU2117297C1 |
METHOD FOR TREATING THE CASES OF OPTIC NERVE ATROPHY | 2001 |
|
RU2192899C1 |
METHOD FOR TREATING THE CASES OF CENTRAL CHOROIDORETINAL DYSTROPHY | 1999 |
|
RU2192242C2 |
Authors
Dates
2003-02-20—Published
2001-09-25—Filed